Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02533336Phase 3Terminated
Phase 3, randomised, open-label trial (2 arms), sponsored by National Institute for Medical Research. Primary endpoint: Incidence of malaria parasitemia at 1 year. Started Nov 2015; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02533336.